CTCAE Grading Scale in Managing Immune- Mediated …

This presentation is the intellectual property of the author. Contact them for permission to reprint and/or Crabbe, MSN, APRN-BC, AOCNCTCAE Grading Scale in Managing Immune- Mediated Adverse EventsThis image cannot currently be display Credit: Disclosure I have nothing to image cannot currently be display Credit: Terminology Criteria for Adverse Events Grade: Refer to the severity of the adverse event (AE). Grade 1: Mild, asymptomatic Management: Observation, intervention not needed. Grade 2: Moderate Management: Local or noninvasive intervention indicated Will likely need low dose oral steroids and may be able to continue treatment Grade 3: Several or medically significant but not immediately life-threatening Management: Stop immunotherapy, hospitalization indicated, high dose steroids Grade 4: Life-threatening consequences Management: Urgent intervention, will permanently stop immunotherapy Grade 5: Death related to AENCI CTCAE image cannot currently be display Credit: AgentsCTLA-4PD-1 PDL-1 image cannot c

Mycophenolate may be useful (immunosuppressant) LFT abnormalities appear to be dose dependent LFT Grade 1 Grade 2 Grade 3 Grade 4 Bilirubin > ULN to 1.5 > 1.5 to 3.0x >3.0 to 10.0x > 10.0 x ULN ALT/AST >ULN to 2.5x >2.5 to 5.0x > 5.0 to 20.0x > 20.0x ULN Albumin <LLN to 3 g < 3 to 2 g/dL < 2 g/dL --

Tags:

  Mycophenolate

Information

Related search queries